The whistleblowing drama behind Astellas’s suspension from the ABPI
When Astellas was reprimanded by the Association of the British Pharmaceutical Industry (ABPI) in June 2016, for “deception on a grand scale which was appalling and shocking,” it received the…
Read Original Article: The whistleblowing drama behind Astellas’s suspension from the ABPI »
